Document is current
Any future updates will be listed below
-
Authors
Heldens, Gijs T. N. https://orcid.org/0000-0003-4912-7806
Driessen, Daphne A. J. J.
Dijkema, Tim
Arens, Anne I. J.
Zámecnik, Patrik
Pegge, Sjoert A. H.
Weijs, Willem L. J.
van Engen-van Grunsven, Adriana C. H.
Takes, Robert P.
Kaanders, Johannes H. A. M.
Scheenen, Tom W. J.
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (2021-2 / 14109)
Radboud Institute for Health Sciences (Junior Research Grant 2017)
- License Information
-
More Information
Article History
Received: 6 June 2025
Accepted: 11 September 2025
First Online: 15 November 2025
Declarations
:
: This research was approved by the institutional review board of the Radboud University Medical Center (CMO Arnhem-Nijmegen) on May 11, 2021, with dossier number 2021-7619, and written informed consent was obtained from all patients. The study was registered in clinicaltrials.gov (NCT04803331).
: Written informed consent for publication of the images and data was obtained from the patient(s).
: Patrik Zámecnik declares to be a Scientific Advisor to SPL Medical B.V. and owner of SPL Medical B.V. stock/options. The other authors declare that they have no conflicts of interest with the content of this article.
